Newsroom

Astorg
in the news

Explore Astorg’s latest announcements and media resources in one place.

AI, and the importance of proprietary data

ViewMore

Value Creation

media

AI, and the importance of proprietary data

Sep 17, 2026

Why Most AI Use Cases in PE Don't Move the P&L

ViewMore

Value Creation

media

Why Most AI Use Cases in PE Don't Move the P&L

Apr 14, 2026

ViewMore

Investors

media

Europe benefiting as investors rebalance portfolios

Sep 25, 2025

Solabia unveils strategic repositioning toward cosmetics and nutraceuticals

ViewMore

Healthcare

news

Solabia unveils strategic repositioning toward cosmetics and nutraceuticals

Oct 20, 2026

Astorg announces plans to combine Oxoid Remel Microbiology and Solabia's microbiology diagnostics division to create a leading global microbiology platform

ViewMore

Healthcare

news

Astorg announces plans to combine Oxoid Remel Microbiology and Solabia's microbiology diagnostics division to create a leading global microbiology platform

Oct 20, 2026

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist

ViewMore

Healthcare

news

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist

Aug 12, 2026

Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform

ViewMore

Healthcare

news

Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform

Jun 4, 2026

Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions

ViewMore

Technology

news

Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions

Jun 1, 2026

Astorg to acquire global microbiology business from Thermo Fisher Scientific

ViewMore

Healthcare

news

Astorg to acquire global microbiology business from Thermo Fisher Scientific

Apr 27, 2026

Overview

Press contacts

Astorg PR Consultants

Prosek Partners (UK)

pro-astorg@prosek.com

Astorg PR Consultants

Steele & Holt (France)

astorg@steeleandholt.com

Astorg updates

Enter your email below to join our mailing list and receive the latest news, insights, and updates from Astorg.

Astorg
in the news

Astorg In the Media

AI, and the importance of proprietary data

Why Most AI Use Cases in PE Don't Move the P&L

Europe benefiting as investors rebalance portfolios

Press Releases

Solabia unveils strategic repositioning toward cosmetics and nutraceuticals

Astorg announces plans to combine Oxoid Remel Microbiology and Solabia's microbiology diagnostics division to create a leading global microbiology platform

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist

Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform

Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions

Astorg to acquire global microbiology business from Thermo Fisher Scientific

Overview

Press contacts

Prosek Partners (UK)

Steele & Holt (France)

Astorg updates

Solabia unveils strategic repositioning toward cosmetics and nutraceuticals

Astorg announces plans to combine Oxoid Remel Microbiology and Solabia's microbiology diagnostics division to create a leading global microbiology platform

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist

Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform

Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions

Astorg to acquire global microbiology business from Thermo Fisher Scientific

Astorgin the news

Astorg In the Media

AI, and the importance of proprietary data

Why Most AI Use Cases in PE Don't Move the P&L

Europe benefiting as investors rebalance portfolios

Press Releases

Solabia unveils strategic repositioning toward cosmetics and nutraceuticals

Astorg announces plans to combine Oxoid Remel Microbiology and Solabia's microbiology diagnostics division to create a leading global microbiology platform

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist

Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform

Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions

Astorg to acquire global microbiology business from Thermo Fisher Scientific

Overview

Press contacts

Prosek Partners (UK)

Steele & Holt (France)

Astorg updates

Solabia unveils strategic repositioning toward cosmetics and nutraceuticals

Astorg announces plans to combine Oxoid Remel Microbiology and Solabia's microbiology diagnostics division to create a leading global microbiology platform

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist

Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform

Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions

Astorg to acquire global microbiology business from Thermo Fisher Scientific

Astorg
in the news